New method for monitoring residual disease after treatment in children with neuroblastoma
A research group led by Professor NISHIMURA Noriyuki (Graduate School of Health Sciences, Kobe University) has developed a new method to monitor the residual disease after treatment in high-risk neuroblastoma patients. The ...
Feb 7, 2020
0
4